The Journal of Allergy and Clinical Immunology
Volume 111, Issue 1 , Pages 91-96 , January 2003

Is there an association between inhaled corticosteroids and bone density in postmenopausal women?

Received 12 April 2002 ,Revised 9 September 2002 ,Accepted 25 September 2002.

References 

  1. Van Staa TP, Leeufkens HGM, Abenhaim B, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res. 2000;15:993–1000
  2. Saag KG, Emkey R, Schnitzer TJ, et al.  Bone loss and glucocorticoid therapy in patients with respiratory disease. Thorax. 1999;54(suppl 2):552–557
  3. Maxwell DL. Adverse effects of inhaled corticosteroids. Biomed Parmacother. 1990;44:421–427
  4. Toogood JH, Baskerville JC, Markov AE, et al.  Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma. J Allergy Clin Immunol. 1995;96:157–166
  5. Toogood JH. Side effects of inhaled corticosteroids. J Allergy Clin Immunol. 1998;102:705–713
  6. Jackson LD, Ploygenis D, McIvor RA, Worington I. Comparative efficacy and safety of inhaled corticosteroids in asthma. Can J Clin Pharmacol. 1999;6:26–37
  7. Cave A, Arlett P, Lee E. Inhaled and nasal corticosteroids: factors affecting the risk of systemic adverse effects. Pharmacotherapy. 1999;83:153–179
  8. Meeran K, Hattersley A, Burrin J, Shiner R, Ibbertson K. Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels. Am J Respir Crit Care. 1995;151:333–336
  9. Storms WW. Clinical adverse effects of inhaled corticosteroids: results of a questionnaire survey of asthma specialists. Ann Allergy Asthma Immunol. 1998;80:391–394
  10. Boyd G. Effect of inhaled corticosteroids on bone. Respir Med. 1994;88:45–52
  11. Lipworth B. Systematic adverse effects of inhaled corticosteroid therapy. Arch Intern Med. 1999;159:941–955
  12. Taylor HL, Jacobs D, Schuker B, Knudsen J, Leon A, Debacker G. A questionnaire for the assessment of leisure time physical activities. J Chron Dis. 1978;31:741–755
  13. Elmståhl S, Riboli E, Lindgärde F, Gullberg B, Saracci R. The Malmö Food Study. The relative validity of a modified diet history method and an extensive food frequency questionnaire for measuring food intake. Eur J Clin Nutr. 1996;50:143–151
  14. Elmståhl S, Gullberg B, Riboli E, Saracci R, Lindgärde F. The reproducibility of a novel diet history method and an extensive food frequency questionnaire. The Malmö Food Study. Eur J Clin Nutr. 1996;50:134–142
  15. Lukaski HC, Johnson PE, Bolonchuk W, Lykken GE. Assessment of fat free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr. 1985;41:810–817
  16. Steen B, Boseaus I, Elmståhl S, Galvard H, Isaksson B, Robertsson E. Body composition in the elderly estimated with an electrical impedance method. Comprehensive Gerontology. 1986;1A:102–105
  17. Augat P, Fuerst T, Genant HK. Quantitative bone mineral assessment at the forearm: a review. Osteoporos Int. 1998;8:299–310
  18. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254–1259
  19. Melton LJ, Atkinson EJ, O'Connor MK, O'Fallon WM, Riggs BL. Bone density and fracture risk in men. J Bone Miner Res. 1998;13:1915–1923
  20. Lane NE, Lukert B. The science and therapy of glucocorticoid-induced bone loss. Endocrinol Metab Clin North Am. 1998;27:465–483
  21. Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res. 2000;15:993–1000
  22. Ebeling P, Erbas B, Hopper J, Wark J, Rubinfeld A. Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticosteroids. J Bone Miner Res. 1998;3:1283–1289
  23. Wong CA, Subakumar G, Casey PM. Effects of asthma and asthma therapies on bone mineral density. Curr Opin Pulm Med. 2002;8:39–44
  24. Bonay M, Bancal C, Crestani B. Benefits and risks of inhaled corticosteroids in chronic obstructive pulmonary disease. Drug Safety. 2002;25:57–71
  25. Luengo M, del Rio L, Ponsand F, Picado C. Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case-control study. Eur Respir J. 1997;10:2110–2113
  26. Ip M, Lam K, Yam L, Kung A, Ng M. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest. 1994;105:1722–1727
  27. Wong CA, Walsh LJ, Smith CJ, et al.  inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet. 2000;355:1399–1403
  28. Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, Lahive K, Leboff MS. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med. 2001;345:941–947
  29. Jones A, Fay JK, Burr M, Stone M, Hood K, Roberts G. Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002;(1):CD003537
  30. Pauwels RA, Lofdahl C-G, Laitinen LA, et al.  Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med. 1999;340:1948–1953
  31. Li JTC, Ford LB, Chervinsky P, et al.  Fluticasone propionate powder and lack of clinically significant effects on hypothalmic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma. J Allergy Clin Immunol. 1999;103:1062–1068
  32. Tattersfield AE, Town GI, Johnell O, et al.  Bone mineral density in subjects with mild asthma randomised to inhaled corticosteroids or non-corticosteroid treatment for two years. Thorax. 2001;56:272–278
  33. Van Staa TP, Leufkens HGM, Cooper C. Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res. 2001;16:581–588

☆ Reprint requests: Sölve Elmståhl, MD, PhD, Department of Community Medicine, Malmö University Hospital, SE-205 02 Malmö, Sweden.

PII: S0091-6749(02)91266-2

doi: 10.1067/mai.2003.4

The Journal of Allergy and Clinical Immunology
Volume 111, Issue 1 , Pages 91-96 , January 2003

Article Tools

* Image Usage & Resolution